市場調査レポート
商品コード
1417941
音声バイオマーカー市場レポート:2030年までの動向、予測、競合分析Speech Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
音声バイオマーカー市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
音声バイオマーカーの動向と予測
世界の音声バイオマーカー市場は、2024年から2030年までのCAGRが16.7%で、2030年までに推定14億9,000万米ドルに達すると予測されています。この市場の主な促進要因は、音声障害の有病率の増加と音声バイオマーカーに対する人々の意識の高まりです。世界の音声バイオマーカー市場の将来性は、精神障害と呼吸不全市場に機会があることから有望視されています。
音声バイオマーカー市場の洞察
Lucintelは、様々な音声障害の評価への利用が増加していることから、予測期間中、頻度が最大セグメントであり続けると予測しています。
この市場の中では、精神障害がより大きなセグメントであり続ける。
北米は主要な製薬会社が進出しているため、予測期間中も最大地域であり続けるでしょう。
Q1.市場規模は?
A1.世界の音声バイオマーカー市場は、2030年までに推定14億9,000万米ドルに達すると予想されています。
Q2.市場の成長予測は?
A2.世界の音声バイオマーカー市場は、2024年から2030年にかけてCAGR 16.7%で成長する見込みです。
Q3.市場の成長に影響を与える主な促進要因は?
A3.この市場の主な促進要因は、音声障害の有病率の増加と音声バイオマーカーに対する人々の意識の高まりです。
Q4.市場の主要セグメントは?
A4.音声バイオマーカー市場の将来は、精神障害および呼吸不全市場に機会があり、有望視されています。
Q5.市場の主要企業は?
A5.主要な音声バイオマーカー企業は以下の通りです。
Q6.今後、最大となる市場セグメントは?
A6.Lucintelは、様々な音声障害の評価への利用が増加していることから、予測期間中、周波数が最大のセグメントであり続けると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は?
A7.北米は主要な製薬会社が進出しているため、予測期間中も最大地域であり続ける。
Q8.レポートのカスタマイズは可能?
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
Speech Biomarker Trends and Forecast
The future of the global speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets. The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030 with a CAGR of 16.7% from 2024 to 2030. The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.
A more than 150-page report is developed to help in your business decisions.
Speech Biomarker by Segment
The study includes a forecast for the global speech biomarker by type, application, and region.
List of Speech Biomarker Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies speech biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the speech biomarker companies profiled in this report include-
Speech Biomarker Market Insights
Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.
Within this market, mental disorder will remain the larger segment.
North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.
Features of the Global Speech Biomarker Market
Market Size Estimates: Speech biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Speech biomarker market size by type, application, and region in terms of value ($B).
Regional Analysis: Speech biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the speech biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the speech biomarker market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the speech biomarker market size?
Answer: The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030.
Q2. What is the growth forecast for speech biomarker market?
Answer: The global speech biomarker market is expected to grow with a CAGR of 16.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the speech biomarker market?
Answer: The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.
Q4. What are the major segments for speech biomarker market?
Answer: The future of the speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets.
Q5. Who are the key speech biomarker market companies?
Answer: Some of the key speech biomarker companies are as follows.
Q6. Which speech biomarker market segment will be the largest in future?
Answer: Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.
Q7. In speech biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.